Morphine Sulfate Tablet, Film Coated, Extended Release
NDC Package 63304-450-03
Package Information
Morphine Sulfate tablets is morphine sulfate extended-release tablets are indicated for the management of severe andpersistent pain that requires an opioid analgesic and that cannot be adequately treated withalternative options, including immediate-release opioids.Limitations of UseBecause of the risks of addiction, abuse, misuse, overdose, and death, which can occur at anydosage or duration and persist over the course of therapy [see Warnings and Precautions(5.2)], reserve opioid analgesics, including morphine sulfate extended-release tablets, for usein patients for whom alternative treatment options are ineffective, not tolerated, or would beotherwise inadequate to provide sufficient management of pain. This formulation utilizes a tablet, film coated, extended release delivery system. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 63304-450 and is authorized under FDA application ANDA078761.
Identification & Billing
- RxCUI: 891874 - morphine sulfate 100 MG Extended Release Oral Tablet
- RxCUI: 891874 - MS 100 MG Extended Release Oral Tablet
- RxCUI: 891881 - morphine sulfate 15 MG Extended Release Oral Tablet
- RxCUI: 891881 - MS 15 MG Extended Release Oral Tablet
- RxCUI: 891888 - morphine sulfate 30 MG Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63304 - Sun Pharmaceutical Industries, Inc.
- 63304-450 - Morphine Sulfate
- 63304-450-03 - 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
- 63304-450 - Morphine Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (63304-450). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63304-450-03 identifies a specific commercial package of 10 tablet, film coated, extended release in 1 bottle of Morphine Sulfate, a human prescription drug labeled by Sun Pharmaceutical Industries, Inc.. This tablet, film coated, extended release is formulated for oral use and contains morphine sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on May 11, 2012. The current certification is valid through December 31, 2027.
How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63304045003. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.